0000899243-18-002320.txt : 20180130
0000899243-18-002320.hdr.sgml : 20180130
20180130184217
ACCESSION NUMBER: 0000899243-18-002320
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180130
FILED AS OF DATE: 20180130
DATE AS OF CHANGE: 20180130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SILVERSTEIN JONATHAN
CENTRAL INDEX KEY: 0001171005
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38359
FILM NUMBER: 18560492
MAIL ADDRESS:
STREET 1: 601 LEXINGTON AVENUE
STREET 2: 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: resTORbio, Inc.
CENTRAL INDEX KEY: 0001720580
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813305277
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 501 BOYLSTON STREET
STREET 2: SUITE 6102
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-482-2333
MAIL ADDRESS:
STREET 1: 501 BOYLSTON STREET
STREET 2: SUITE 6102
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-30
0
0001720580
resTORbio, Inc.
TORC
0001171005
SILVERSTEIN JONATHAN
C/O RESTORBIO, INC.
500 BOYLSTON STREET, 12TH FLOOR
BOSTON
MA
02116
1
0
1
0
Common Stock
2018-01-30
4
C
0
2425485
A
2425485
I
See Footnotes
Common Stock
2018-01-30
4
C
0
1871569
A
4297054
I
See Footnotes
Common Stock
2018-01-30
4
P
0
533333
15.00
A
4830387
I
See Footnotes
Series A Preferred Stock
2018-01-30
4
C
0
2425482
0.00
D
Common Stock
2425485
0
I
See Footnotes
Series B Preferred Stock
2018-01-30
4
C
0
1871569
0.00
D
Common Stock
1871569
0
I
See Footnotes
Represents the total number of shares of Common Stock received by the Reporting Person upon conversion of the Issuer's Series A Preferred Stock in connection with the closing of the Issuer's initial public offering.
The shares are held of record by OrbiMed Private Investments VI, LP("OPI VI"). OrbiMed Capital GP VI LLC ("GP VI") is the sole general partner of OPI VI, and OrbiMed Advisors LLC ("Advisors"), a registered adviser under the Investment Advisers Act of 1940, as amended, is the sole managing member of GP VI. By virtue of such relationships, GP VI, and Advisors may be deemed to have voting and investment power with respect to the securities held by OPI VI noted above and as a result may be deemed to have beneficial ownership over such securities. The Reporting Person is a member of Advisors.
Each of GP VI, Advisors, and the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any such entity or person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Represents the total number of shares of Common Stock received by the Reporting Person upon conversion of the Issuer's Series B Preferred Stock in connection with the closing of the Issuer's initial public offering.
All series of Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1.2804-for-1 basis on January 30, 2018 and had no expiration date.
/s/ Jonathan Silverstein
2018-01-30